REDDING, Calif., May 13, 2024 /PRNewswire/ -- According to a new
market research report titled, 'Clinical Lab Automation
Market Size, Share, Forecast, & Trends Analysis by
Product (Liquid Handling, Nucleic Acid Purification System,
Microplate Reader, Automated ELISA, Software), End User (Hospitals,
Diagnostic Laboratories) – Global Forecast to 2031,'
published by Meticulous Research®, the clinical lab
automation market is projected to reach $4.01 billion by 2031, at a CAGR of 7.8% from
2024 to 2031.
Download Sample Report Now-
https://www.meticulousresearch.com/download-sample-report/cp_id=5762
Clinical lab automation involves the utilization of automated
devices and instruments in various procedures conducted in clinical
laboratories or hospitals. This automation offers numerous
advantages, including reduced human errors, cost savings, increased
productivity, accelerated diagnostic speed, and improved efficiency
in handling larger workloads without the need for a proportional
increase in staffing.
The growth of this market can be attributed to the rising global
geriatric population, the increasing prevalence of infectious
diseases, and technological advancements in clinical laboratory
instruments. However, the high costs of advanced clinical lab
automation equipment, coupled with funding and infrastructure
limitations in developing countries, restrain the growth of this
market.
Furthermore, the increasing demand for automated instruments,
technological advancements in molecular diagnostics, and emerging
economies are expected to create market growth opportunities.
However, factors such as high equipment maintenance and repair
costs and concerns over the security and privacy of patient data
pose challenges for the market's growth.
Increasing Applications of Next-generation Sequencing
Technology
Next-generation sequencing (NGS) technology has significantly
reduced DNA sequencing costs. Moreover, it has revolutionized the
field of genetic disease diagnostics with rapid, high-throughput,
and cost-effective approaches. NGS can simultaneously analyze
hundreds of genes, the whole exome, and the whole genome, enabling
researchers to gain a deeper understanding of the genetic
heterogeneity of rare diseases. NGS technologies allow for
understanding unknown species and complex diseases. This technology
has recently gained much traction in diagnosing infectious
diseases, immunological disorders, and hereditary disorders. It is
also widely used for non-invasive prenatal diagnosis and
therapeutic decision-making for somatic cancers.
Get a Glimpse Inside: Request Sample Pages-
https://www.meticulousresearch.com/request-sample-report/cp_id=5762
Next-generation sequencing technologies, including DNA and RNA
sequencing, provide 'omics' approaches to help understand the
genomics, transcriptomic, and epigenomic landscapes of individual
cancers. NGS has great potential to enhance cancer diagnosis and
care. Using NGS technology, a variety of genomic aberrations, such
as common and rare variants, structural variations (e.g.,
insertions and deletions), copy-number variations, and fusion
transcriptions can be screened simultaneously.
The use of automated NGS instruments in clinical diagnosis
offers several advantages. It offers shorter turn-around times,
minimizes the need for manual intervention, provides fast and
accurate results, and reduces the risk of contamination or nucleic
acid crossover between sample runs. The players operating in this
market are focused on the development of advanced NGS solutions.
For instance, in December 2021, F.
Hoffmann-la Roche AG (Switzerland)
launched the AVENIO Edge System, which is an automated NGS solution
for sample preparation workflows, to support comprehensive testing
with high-quality results and minimized errors and help advance
personalized medicine.
The global clinical lab automation market is segmented by
Product (systems {automated liquid handling systems, automated
ELISA systems, automated nucleic acid purification systems,
automated microplate readers, and other systems}, clinical lab
automation software), End User (hospital laboratories, diagnostic
laboratories, and other end users) and Geography. The study also
evaluates the market at the regional and country levels.
Based on product, in 2024, the systems segment is expected to
account for the largest share of 84.3% of the clinical
lab automation market. The large market share of this segment
is attributed to the benefits of clinical lab automation systems,
which facilitate procedures without manual intervention, enhancing
laboratory testing capabilities. These systems mitigate
repetitive tasks and errors, resulting in increased throughput and
efficiency, ultimately improving the quality of test
results.
Have Specific Research Needs? Request a Customized
Report-
https://www.meticulousresearch.com/request-customization/cp_id=5762
Based on end user, in 2024, the hospital laboratories segment is
expected to account for the large market share of 49.6% of
the clinical lab automation market. The large share of the segment
is attributed to factors such as rising healthcare expenditure,
increasing prevalence of chronic diseases, increasing sample loads
in hospitals, and improving healthcare infrastructure in developing
countries.
Geographically, in 2024, North
America is expected to account for the largest share of
41% of the clinical lab automation market. The
North America clinical lab
automation market is estimated to be worth USD 957 million in 2024. North America's major market share is
primarily attributed to highly developed diagnostics
infrastructure, a high number of laboratory tests performed
annually, and the rising prevalence of chronic diseases coupled
with the growth in the aging population. The U.S. is expected to
account for the larger share of the clinical lab automation market
in North America. The growth of
this market in the U.S. is attributed to increased demand for
automation due to the high sample load in clinical laboratories,
the country's highly developed healthcare infrastructure, the
rising prevalence of chronic diseases, the aging population, and
the presence of large diagnostics companies.
However, the Asia-Pacific
clinical lab automation market is slated to register the highest
CAGR during the forecast period. The growth of this regional market
is mainly driven by increasing investment by healthcare providers
towards infrastructure improvement, the need to manage the growing
burden of infectious diseases, the rising demand for clinical
testing, supportive government initiatives to improve the
accessibility to diagnostic services, and the need to establish
more diagnostic laboratories
The report also includes an extensive assessment of the key
growth strategies adopted by leading market players over the past
three to four years. The global clinical lab automation market has
witnessed product launches, collaborations, agreements, and
expansions in the last couple of years.
Some of the key players operating in the global clinical lab
automation market are Thermo Fisher Scientific, Inc. (U.S.),
Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.),
Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F.
Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc.
(U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG
(Germany), Becton, Dickinson, and
Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc.
(U.S.), and Hamilton Company (U.S.).
Browse the In-depth Report-
https://www.meticulousresearch.com/product/clinical-lab-automation-market-5762
Scope of the Report:
Clinical Lab Automation Market Assessment–by
Product
- Systems
- Automated Liquid Handling Systems
- Automated ELISA Systems
- Automated Nucleic Acid Purification Systems
- Automated Microplate Readers
- Other Systems
- Clinical Lab Automation Software
Note: Other systems include automated incubators, automated
cell counters, and cell imaging systems
Clinical Lab Automation Market Assessment–by End User
- Hospital Laboratories
- Diagnostic Laboratories
- Other End Users
Note: Other end users include blood banks, forensic labs, and
clinical research organizations.
Clinical Lab Automation Market Assessment–by
Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa
Unlock Opportunities: Buy Now-
https://www.meticulousresearch.com/Checkout/441181684
Related Reports:
Lab Automation Market - Global Opportunity Analysis
and Industry Forecast (2024-2031)
Laboratory Information Management System (LIMS)
Market - Global Opportunity Analysis And Industry Forecast
(2023-2030)
Laboratory Informatics Market - Global Opportunity
Analysis and Industry Forecast (2023-2030)
NGS Automation Market - Global Opportunity Analysis
and Industry Forecast (2022-2029)
Related Blogs:
Top 10 Companies in Clinical Lab Automation
Market
The Impact of Clinical Lab Automation on Healthcare
Efficiency
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as
Meticulous Market Research Pvt. Ltd. in 2013 as a private limited
company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market
intelligence in North America,
Europe, Asia-Pacific, Latin
America, and the Middle
East & Africa.
The name of our company defines our services, strengths, and
values. Since the inception, we have only thrived to research,
analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research
techniques, we have built strong capabilities in data collection,
interpretation, and analysis of data including qualitative and
quantitative research with the finest team of analysts. We design
our meticulously analyzed intelligent and value-driven syndicate
market research reports, custom studies, quick turnaround research,
and consulting solutions to address business challenges of
sustainable growth.
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn-
https://www.linkedin.com/company/meticulous-research
Content Source:
https://www.meticulousresearch.com/pressrelease/997/clinical-lab-automation-market-2031
Logo:
https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/clinical-lab-automation-market-to-be-worth-4-01-billion-by-2031---exclusive-report-by-meticulous-research-302143478.html